Tessellate BIO
Naarden
About Tessellate BIO
Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques. It develops precision oncology methods to treat tumors with significant unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Funding stage: Seed
- Last round: Seed (Oct 2023)
- Website: tessellatebio.com
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/tessellate-bio-127951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.